Press Release
Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2…
NEW YORK, NY, May 02, 2026 (GLOBE NEWSWIRE) — With the 61st Venice Biennale Arte…
NEW YORK, May 02, 2026 (GLOBE NEWSWIRE) — As financial markets become increasingly driven by…
Decades of Service: A Western Rooter & Plumbing technician performing residential service. The company has…
CAIRNS, Australia, May 02, 2026 (GLOBE NEWSWIRE) — SaintQuant has launched its free AI Crypto…
LOS ANGELES, May 02, 2026 (GLOBE NEWSWIRE) — In response to the growing complexity and…
LAS VEGAS, May 02, 2026 (GLOBE NEWSWIRE) — Embodied Love University, founded by Dr. Saida…